Lexa Tablet contains a combination of Melatonin (3mg) and Zolpidem (10mg), formulated to aid in the management of insomnia and other sleep disorders. Melatonin is a naturally occurring hormone that regulates the sleep-wake cycle, promoting the onset of sleep by signaling the body’s internal clock. Zolpidem is a non-benzodiazepine hypnotic agent that acts selectively on the GABA-A receptor complex, facilitating the initiation and maintenance of sleep through its sedative properties. The synergistic effect of Melatonin and Zolpidem in Lexa Tablet provides both physiological regulation of circadian rhythms and pharmacological sedation, making it effective for patients experiencing difficulty falling asleep or maintaining sleep continuity. Lexa Tablet is indicated for short-term treatment of insomnia characterized by delayed sleep onset and frequent awakenings. It should be used under medical supervision, particularly in patients with a history of substance abuse, respiratory impairment, or hepatic dysfunction. Common adverse effects may include dizziness, headache, and daytime drowsiness. Caution is advised when performing tasks requiring alertness. Lexa Tablet is contraindicated in individuals with hypersensitivity to its components and should not be combined with other central nervous system depressants without professional guidance. Proper adherence to prescribed dosage and duration is essential to minimize the risk of dependence and tolerance.